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Abstract 
We investigated associations between serum perfluoroalkyl acid (PFAA) concentrations in 
children aged 4, 8, and 12 years (sampled in 2008-2015; n=57, 55, and 119, respectively) and 
exposure via placental transfer, breast-feeding, and ingestion of PFAA-contaminated drinking 
water. Sampling took place in Uppsala County, Sweden, where the drinking water has been 
historically contaminated with perfluorobutanesulfonate (PFBS), perfluorohexanesulfonate 
(PFHxS), perfluorooctanesulfonate (PFOS), perfluoroheptanoate (PFHpA), and 
perfluorooctanoate (PFOA). PFOS showed the highest median concentrations in serum (3.8-
5.3 ng g-1 serum) followed by PFHxS (1.6-5.0 ng g-1 serum), PFOA (2.0-2.5 ng g-1 serum), 
and perfluorononanoate (PFNA) (0.59-0.69 ng g-1 serum) in children. Including all children, 
serum PFOA, PFHxS, and PFOS concentrations in children increased 10%, 10%, and 1.3% 
(adjusted mean), respectively, per unit (ng g-1 serum) of increase in maternal serum level (at 
delivery), the associations being strongest for 4-year-old children. PFHxS and PFOS 
significantly increased 3.9% and 3.8%, respectively, per month of nursing, with the highest 
increase for 4-year-olds. PFOA, PFBS, PFHxS, and PFOS increased 1.2%, 207%, 7.4%, and 
0.93%, respectively, per month of cumulative drinking water exposure. Early life exposure to 
PFOA, PFHxS, and PFOS is an important determinant of serum concentrations in children, 
with the strongest influence on younger ages. Drinking water with low to moderate PFBS, 
PFHxS, PFOS, and PFOA contamination is an important source of exposure for children with 
background exposure from other sources.  
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Introduction 
Per- and polyfluoroalkyl substances (PFASs) are synthetic highly fluorinated substances that 
have been produced in large volumes and which have broad commercial applications. PFASs 
are ubiquitous in humans and the environment. Human exposure media include food, 
drinking water, dust, air and products containing PFASs.1 2 3 Perfluoroalkyl acids (PFAAs) 
are a class of PFASs which are intentionally manufactured, but which may also occur from 
degradation of other PFASs (i.e. PFAA-precursors).4 5 PFAAs display extreme environmental 
persistence and chain length-dependent bioaccumulation in humans.6, 7 
For the general population, exposure to PFAAs via placental transfer8-11 and ingestion of 
mother´s milk12-14 are major determinants of blood PFAAs concentrations in infants.15-20 In 
fact, exposure to certain PFAAs via breast milk as an infant represents a significant fraction 
of a child’s overall exposure up to 3-5 years of age, most probably due to the long half-lives 
of these PFAAs in the body.21, 22 Other exposure media like diet, drinking water, dust and air 
contribute to a greater extent as the child gets older.22-26 Early life exposure to some PFAAs 
during pregnancy has been associated with lower birth weight 27-29 and increased childhood 
adiposity. 30-33 Positive associations between maternal PFAA levels during pregnancy and 
children’s weight or body mass index (BMI) have also been reported 29, 31, 34 along with 
relations to immune toxicity in children.35, 36 Improved knowledge of the determinants of 
blood PFAA concentrations in infants/children, in particular in scenarios involving point 
source contamination (e.g. contaminated drinking water) is needed for understanding the 
exposure sources responsible for observed relationships between blood PFAA concentrations 
and health outcomes. 
Drinking water in the City of Uppsala, Sweden, was contaminated with PFAAs for at least 20 
years 37 before the contamination was discovered in 2012 and affected production wells were 
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closed or severely restricted. Perfluorohexane sulfonate (PFHxS) was the most prevalent 
PFAA in the contaminated production wells at the time of well closure (mean 80 ng L-1) 
followed by perfluorooctane sulfonate (PFOS; 50 ng L-1) and perfluorobutane sulfonate 
(PFBS; 10 ng L-1) 37. Uppsala is thus a good setting for studies investigating different sources 
of PFAA exposure (e.g. trans-placental transfer, mother´s milk, drinking water) as 
determinants of blood PFAA concentrations during childhood.  
In a previous study of 2-4-month-old infants from Uppsala participating in the POPUP cohort 
(Persistent Organic Pollutants in Uppsala Primiparas) it was shown that prenatal and 
postnatal PFAA exposure significantly contributed to the serum concentrations in infants and 
that maternal PFHxS and PFBS exposure from drinking water was an important indirect 
infant exposure source. 38 
The aim of the present study was to investigate determinants of PFAA serum concentrations 
in older children at ages 4, 8, and 12 years, from the POPUP cohort, focussing on maternal 
PFAA concentrations at the time of delivery, nursing history of the child, and history of 
drinking water exposure of the child. Specific research objectives addressed here include: a) 
determining the contribution of PFAA exposure in utero and during nursing at different ages 
of children and b) to assess the extent to which PFAA exposure via medium grade 
contaminated drinking water (10-100 ng/l of single PFAAs) is a determinant of PFAA serum 
concentrations during childhood in a population with background exposure from other 
sources.  
 
Materials and methods 
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Sampling 
All mother/child pairs included in the present paper are participants in the POPUP study, an 
on-going investigation of POPs in first-time mothers and their children in Uppsala County, 
Sweden. Mothers were randomly recruited during pregnancy (1996-1999) or shortly after 
delivery (2000-2011).39, 40 The mothers answered a self-administered questionnaire about 
life-style factors and health of the mother and child. Information about nursing was given by 
the mother, answering for each month after birth up to 13 months, if the child had been only-, 
part time-, or not breastfeeding. Blood samples from the mothers were collected 3 weeks after 
delivery. Following up on this, serum samples were collected from the children when they 
were 4-, 8-, and 12 years of age between 2008 and 2015 (n=57, n=55, and n=119, 
respectively; Fig. 1). None of the children were sampled at all ages, in total 33 children were 
sampled twice (n=13 at age 4 and 8 and n=20 at age 8 and 12). Detailed characteristics of the 
children are provided in Table 1. Plastic Vacutainer® or Vacuette® serum tubes were used for 
blood sampling and serum was stored at -20°C until analysis. The study was approved by the 
local ethics committee in Uppsala, Sweden (dnr 2004/177 and 2007/147/1), and the 
participating women and children gave informed consent. 
 
Chemical analyses 
A total of 13 PFAAs were targeted in the present work, including C4, C6 and C8 
perfluoroalkane sulfonic acids (PFSA; i.e. PFBS, PFHxS, PFOS) and C6-C15 perfluoroalkyl 
carboxylic acids (PFCA; i.e. PFHxA, PFHpA, PFOA, PFNA, PFDA, PFUnDA, PFDoDA, 
PFTrDA, PFTeDA, PFPeDA; for details see Supporting Information, Table A1). The serum 
samples were analysed as described previously.37 In short, 0.5 g serum was spiked with 
internal standards and extracted with acetonitrile in an ultrasonic bath. The concentrated 
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extract underwent dispersive clean-up with graphitized carbon. Aqueous ammonium acetate 
and volumetric standards were added before analysis on an Acquity ultra performance liquid 
chromatography system (UPLC) coupled to a Xevo TQ-S tandem mass spectrometer 
(MS/MS; both Waters Corp., Milford, MA, U.S.) operated in negative electrospray 
ionization, multiple reaction monitoring mode. Instrumental parameters are provided in 
Supporting Information, Table A2. 
Quantification was performed by isotope dilution using a 5-point calibration curve (linear, 
1/x weighting), which was run before and after samples. For most targets, analogous 
isotopically labelled internal standards were available. For PFBS, PFTrDA, PFTeDA, and 
PFPeDA, a structurally similar internal standard was used (Supporting Information, Table 
A2). For PFHxS and PFOS, ∑branched (br) and linear (lin) isomers were quantified 
separately using the calibration curve for the lin isomer and the concentrations for the m/z 
499/80 and 499/99 product ions were averaged, as described in Riddell et al.41 
A procedural blank and a quality control (QC) sample (pooled human serum analyzed 
repeatedly in-house) were included with every batch of samples to assess background 
contamination and reproducibility, respectively (see Supporting Information Table A3 for QC 
performance metrics). In addition, three replicates of standardized and certified reference 
material from NIST (SRM 1957) were analyzed, and quantified concentrations were 
compared to reference values to assess method accuracy (results provided in Supporting 
Information Tables A4 and A5). Measured concentrations in SRM 1957 were consistent with 
reference values for all targets, while CVs in control serum (n=8) ranged from 11-30%, with 
the exception of PFBS (41%), which was close to detection limits and only intermittently 
detected in control serum. For targets observable in method blanks, the detection limit was 
based on the mean blank + 3× the standard deviation of the blanks. For targets absent in 
blanks, detection limits were based on a signal to noise ratio of 3. The method quantification 
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limits (MQL) were 0.16 ng g-1 serum for PFHxA, 0.08 ng g-1 serum for PFHpA, 0.8 ng g-1 
serum for PFOA, 0.08 ng g-1 serum for PFNA, 0.10 ng g-1 serum for PFDA and PFUnDA, 
0.08 ng g-1 serum for PFDoDA, 0.02 ng g-1 serum for PFTrDA, 0.06 ng g-1 serum for 
PFTeDA, 0.01 ng g-1 serum for PFPeDA, 0.01 ng g-1 serum for PFBS, PFHxS, and PFOS.  
 
Exposure via drinking water 
Data on the occurrence of PFAAs in drinking water were only available for a few samples 
(n=9) collected at the tap in different parts of Uppsala County in 2012, when PFAA 
contamination was first discovered.42 A study of PFAA concentrations in maternal serum 
from 1996 to 2011 revealed that the drinking water was already contaminated during the 
initial study period (1996-1999).37 Modeling the distribution of contaminated well water from 
1996 to 2012 made it possible to estimate the extent of exposure to PFAA-contaminated 
water depending on location of residence within Uppsala County.37 
The cumulative number of months with PFAA exposure from drinking water (DWcumexp) 
were calculated for the five PFAAs that were detected in the drinking water: PFHpA, PFOA, 
PFBS, PFHxS, and PFOS. Details of the distribution patterns of PFAA-contaminated 
drinking water in Uppsala City from 1996 to 2012 were collected, and an overview of the 
distribution was obtained by modeling.37 This information revealed that residential addresses 
of the children over the duration of the study (data obtained from the Swedish Population 
Register) could be divided into four different PFAA drinking water districts (up to July 2012; 
thereafter contamination was mitigated), with District 1 not receiving a contribution from 
PFAA-contaminated wells, and Districts 2, 3, and 4 receiving contributions of <10%, 10-89% 
and ≥90%, respectively, from the contaminated wells. In the calculations of the DWcumexp 
each child was assigned to a district based on home address for each month of life until blood 
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sampling. Children assigned to District 1 were estimated to have been exposed to 0% of the 
contaminated water on a monthly basis (DWexp=0), while children in Districts 2, 3, and 4 
were estimated to have been exposed to 5%, 50%, and 95%, respectively, of contaminated 
water (DWexp=0.05, 0.50, and 0.95). After July 2012, it was assumed that no district received 
contaminated water (i.e. DWexp =  0). 
In the next step, each DWexp was half-life-adjusted based on the number of months between 
the month in question and blood sampling. The half-lives (T1/2) used were 70 days (2.3 
months) for PFHpA,43 26 days (0.87 months) for PFBS,44 2.7 years (32 months) for PFOA, 
5.3 years (64 months) for PFHxS, and 3.4 years (41 months) for PFOS.45  
Each participant´s cumulative number of months with exposure to a given PFAA from 
drinking water (DWcumexp) could thus be estimated by the formula: (see Supporting 
Information Table A6 for example calculations).  
𝐷𝑊𝑐𝑢𝑚𝑒𝑥𝑝 =∑𝐷𝑊𝑒𝑥𝑝𝑖 ∗
1
2
(𝑛−𝑖)/𝑇
𝑛
𝑖=1
 
DWexpi = proportion of contaminated water in the drinking water during month i (0, 0.05, 0.5, or 0.95) 
T1/2 = half-life of the PFAA 
n = number of months from birth to blood sampling, i.e. (n–i) = number of months from month i to 
blood sampling) 
 
Statistical analyses 
MINITAB 15® Statistical Software for Windows was used for all statistical analyses. When 
PFAA concentrations were below the MQL, MQL/√2 was used in the statistical analyses. 
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The proportions of br and lin isomers for PFHxS and PFOS were expressed as a percentage 
of the total concentration. Correlations among serum PFAAs were investigated using average 
linkage cluster analysis, which is a hierarchical analysis clustering method based on the 
average distance between all pairs of objects. Kruskal-Wallis test was used to evaluate 
possible differences in serum PFAA concentrations among children aged 4, 8, and 12 years. 
General linear model (GLM) analysis was used to investigate differences in serum PFAA 
concentrations between age groups, adjusted for sampling year and drinking water exposure. 
Multiple linear regressions (MLR) were used to analyze associations between PFAA 
concentrations in child serum and maternal PFAA level at delivery, duration of breastfeeding 
during infancy, and childhood drinking water exposure. When analyzing %br PFHxS or 
PFOS in children, the maternal serum %br PFHxS or PFOS was included instead of maternal 
concentrations of PFHxS or PFOS. These MLR analyses were not performed for PFAAs 
where >25% of the reported concentrations were below MQL, except for PFHpA and PFBS 
when analyzing the influence of drinking water exposure on serum concentrations. PFHpA 
and PFBS have relatively short serum half-lives (70 and 26 days, respectively43, 44); 
consequently, maternal PFAA levels at delivery and duration of breastfeeding are not 
expected to make a significant contribution to serum PFAA levels in children and were 
therefore not included as exposure sources. The associations between child PFAA 
concentrations and other determinants (i.e. age at sampling, sampling year, body weight, and 
sex) were first analyzed in univariate linear analyses and those associated with PFAA 
concentrations at p≤0.1 significance levels were included in the MLR model.  
In addition, stepwise regression was used to estimate how much of the variation in PFAA 
concentrations was explained by the variation of the determining factors. Logarithmically- 
transformed PFAA concentrations were used in the statistical analyses, since the distribution 
of data closely followed a log-normal distribution. As a consequence, partial regression 
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coefficients (β) of the independent variables may be interpreted as % change in serum 
concentrations of PFAA per unit of change in the independent variable, calculated as 
%change = (1-exp(β))*100. In the analyses of all children (aged 4, 8, and 12) together, only 
results from one sampling age were used for children that were sampled more than once 
(n=33). For children sampled both at 8 and 12 years of age, the results from age 8 were used, 
due to a smaller sample size than among 12-year-old children. Children sampled both at 4 
and 8 years of age were allocated equally into the two age groups, as the sample sizes were 
similar. A sensitivity test was performed when observations with standardized residuals ≥3 
were excluded from analysis due to their large influence on the regression results. The 
statistical significance was set to p≤0.05. 
 
Results and discussion 
PFAA serum concentrations 
PFAA serum concentrations in children at different ages are presented in Table 2 (PFCAs) 
and Table 3 (PFSAs). For the investigated sampling years (i.e. 2008-2015), total PFOS, total 
PFHxS, and PFOA displayed the highest median concentrations in children’s serum, in all 
age groups. Significant differences were observed between PFAA concentrations in 4-, 8-, 
and 12-year-olds (p<0.05; Kruskal-Wallis test) for all detected targets, except PFUnDA, 
PFTrDA, and PFBS. For PFHpA, PFOA, and PFHxS the highest concentrations were 
observed in 4-year-olds, while PFOS concentrations increased with increasing age. No 
general age-dependent pattern was observed for PFNA and PFDA. However, due to 
differences in timing of sampling between age groups (Fig. 1) and possible differences in 
drinking water exposure, it is more relevant to compare age-dependent differences in 
concentrations after adjustment of concentrations for sampling year and half-life-adjusted 
12 
 
months of contaminated drinking water. In this case (using GLM), PFHpA, PFOA, and 
PFHxS serum concentrations were significantly higher among 4-year-old children compared 
to 8- and 12-year-olds (Fig. 2), and PFHpA, PFNA and PFDA were significantly higher in 8- 
compared to 12-year-olds.  
For comparison, blood PFAA concentrations in children from other studies during the same 
time period are provided in the Supporting Information, Table A7. Studies reporting age-
dependent differences in PFAA concentrations among children have observed diverging 
results. 46, 47 36, 48 49 50 51-53 The comparisons are, however, hampered by differences among 
studies with respect to study design, location, child age, nursing history, and sampling year. 
Taking these uncertainties into account, there are few marked differences in PFAA 
concentrations between children from Uppsala examined in the present study, and those with 
background exposure from Denmark, the Faroe Islands, Germany, and the U.S. 46, 47 36, 48 49 50 
51 The few exceptions include PFNA, where higher serum levels were reported in two studies 
from the U.S.,46, 47 and PFHxS, where concentrations in children’s serum in the present study 
are elevated, most likely due to drinking water exposure.37 Moreover, 3-6-fold higher 
concentrations of PFOS, PFDA, PFUnDA, and PFTrDA, and 30-fold higher concentrations 
of PFBS were reported in serum from children in South Korea and Taiwan compared to the 
present study.52, 53 
Historical production of PFOS, its salts and derivatives by the major global manufacturer (the 
3M Company) resulted in a technical mixture of about 70% lin and 30% ∑br isomers.5 The 
major technical PFOS mixture (3M) contained impurities of PFHxS consisting of about 82% 
lin and 18% br PFHxS isomers.54 Previous studies in adults have reported a slightly higher 
percentage of br PFOS isomers in human serum than in the historical technical mixture.37, 55 
This is supported by our finding of 37% br PFOS isomers (median) in POPUP children 
(Table 3). The %br PFHxS and PFOS are in agreement with the values observed in 3-month-
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old POPUP infants and their mothers sampled in 1996-1999.38 The differences in %br PFHxS 
and PFOS in children in relation to technical mixtures may for instance be due to differences 
in historical PFHxS and PFOS exposure patterns and sources or how the content of br 
isomers has been determined analytically. The difference may also be explained by different 
toxicokinetics of lin and br isomers in humans 9 56 or that the children in the present study 
have been exposed to PFAS-contaminated drinking water (see discussion below). Studies of 
PFAA isomers in children are scarce, and to our knowledge this is the first study of serum 
concentrations of br and lin PFHxS in children. In Danish children aged 6-11 years sampled 
in 2011, the median br PFOS content in serum was 32% 48 and 29% in children aged 6-10 
years sampled 2007-2010 in the U.S.46 We did not observe any age differences in %br PFOS 
and PFHxS isomers in the Uppsala children (Table 3), suggesting that differences in 
elimination rates between br and lin isomers 57 are not significant determinants of the 
proportions of br and lin isomers in serum during childhood. 
Cluster analysis of PFAA based on correlations between serum concentrations in 4-, 8-, and 
12-year-old children are shown in Figure 3. PFBS and PFHxS clustered together in the 
children in the present study, which may be due to drinking water being a common source of 
exposure in the Uppsala children, as shown in their mothers.37 Long-chain PFCAs and PFOS 
clustered separately from PFBS and PFHxS as well as from PFOA and PFHpA (Fig. 3). 
Apart from drinking water exposure as a possible explanation to the separate clustering of 
PFBS and PFHxS, differences in dietary sources could explain separate clustering of long-
chain PFCAs/PFOS and PFOA. A study of PFASs in food on the Swedish market showed 
that in 2010 fish consumption contributed with more than 80% of total per capita exposure of 
long-chain PFCAs and PFOS from food, whereas PFOA intake from fish consumption was 
estimated to be  ≤10% of total per capita exposure .3 Sub-clustering of PFUnDA and PFTrDA 
separately from PFNA, PFDA, and PFOS within the same hierarchy (Fig. 3) points to fish 
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consumption as a common source of exposure to these PFASs, but more so for PFUnDA and 
PFTrDA compared to PFNA, PFDA, and PFOS.3 
 
Determinants for PFAA in children sampled 2008-2015 
All 4-, 8-, and 12-year-old children were first analyzed together in order to increase statistical 
power (n=198), and the results are given in table 4. In the next step, the different age groups 
were analyzed separately to determine age-related difference regarding associations between 
maternal concentrations at delivery and breastfeeding duration and child concentrations 
(Table 5). In Supporting Information, the results from all analyzed PFAA at the different ages 
are presented in table A10. 
In the MLR analyses, including all children, age-dependent differences in adjusted mean 
PFAA concentrations were less obvious (Supporting Information, Table A8) than in the 
GLM-analyses adjusting only for sampling year and drinking water exposure (Fig. 2). 
Consequently, the age differences observed in the GLM-analyses after adjustment for only 
sampling year and drinking water exposure were to some extent due to the influence of the 
other determinants of serum PFAA concentrations investigated in the present work, such as 
maternal serum concentration, breastfeeding, weight, and sex (Table 4).  
The influence of fetal and postnatal lactation exposure on child serum PFAA levels was 
investigated by including the variables “maternal serum concentrations at delivery” and 
“breastfeeding duration” in the MLR model, except for PFHpA and PFBS, which have 
relatively short half-lives in serum. When including all children in the MLR analyses, 
increased maternal serum concentrations (at delivery) were associated with increased child 
serum concentration for PFHxS (coefficient of determination (R2) =0.11), PFOA (R2=0.04), 
and PFOS (R2=0.03).  
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Maternal PFAA concentrations at birth most probably reflect both in utero and lactational 
exposure of the children, since maternal serum/plasma concentrations of PFHxS, PFOS, 
PFOA, PFNA, PFDA, and PFUnDA during pregnancy and close to delivery are strongly 
correlated with PFAA concentrations both in cord blood and mother´s milk.12, 18 58 8 19 59  For 
PFOA, PFHxS and PFOS, the impact of early exposure was greater in 4-year-old children 
compared to the older age groups (Table 5). For example, PFOA serum concentrations in the 
4-year-olds increased 29% per unit (ng g-1 serum) of increase in maternal serum PFOA level 
(R2=0.24), whereas in 12-year-olds the increase was 8.4% (R2=0.04). 
The strong association between levels of PFOA, PFHxS, and PFOS in serum of mothers at 
the time of delivery and 4-year-olds but not in the older age groups may be due to a 
combination of growth dilution of PFAAs accumulated in utero and during nursing, a longer 
period of excretion of PFAAs that were accumulated early in life among the older children, 
and an increased contribution of PFAAs accumulated for instance from food among older 
children. For the long-chain PFCAs, PFNA and PFDA, we observed no associations between 
early life exposure and serum concentrations in the children, suggesting that early life 
exposure to these PFAAs have little influence on concentrations later in childhood. Similarly, 
in 3-month-old POPUP infants the influence of maternal PFAA concentrations at delivery 
decreased with increasing perfluoroalkyl chain length.38 Factors other than early life exposure 
are apparently more important in determining concentrations of PFDA and PFNA than for 
PFOA, PFHxS, and PFOS. 
Percent of br PFOS in children increased with increasing %br in maternal serum at delivery, 
whereas no such association was found for PFHxS (Tables 4 and 5). When stratifying for 
child age, the associations for %br PFOS were positive in all three age groups but only 
significant for 8- and 12-year-olds. The positive association between %br PFOS in mothers at 
delivery and %br PFOS in the children suggest significant maternal influence on PFOS 
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isomer patterns in children for many years after birth. This could, apart from the remaining 
influence from in utero and breastfeeding exposure, mirror similar food habits and exposure 
sources between mothers and their children. 
PFOA (only in 4-year-olds), PFHxS, and PFOS were associated with breastfeeding duration, 
showing an increase with increased breastfeeding duration with partial R2=0.01 and 0.04, for 
PFHxS and PFOS respectively and 0.05 for PFOA in 4-year-olds (Table 4 and 5). As shown 
by the R2s, only a small percentage of variation of child PFAA concentrations were explained 
by the in utero and breastfeeding exposure, most likely due to greater contribution of PFAA 
exposure during the years after cessation of breastfeeding. Moreover, since the mothers gave 
the information on breastfeeding several years after the breastfeeding period, recall bias may 
also have contributed to the low R2s. 
Duration of breastfeeding showed a similar age-dependent influence on child PFOS and 
PFOA concentrations as maternal PFOS and PFOA serum concentrations at delivery. Serum 
PFOA concentrations increased 5.1% per month of breastfeeding (R2=0.05) in 4-year-olds, 
but at 8 and 12 years of age no associations were found. Serum concentrations of PFOS in 4-
year-olds increased 7.9% per month of breastfeeding (R2=0.10), 5.3% per month for 8-year-
olds (R2=0.08), and for 12-year-olds the association was not significant.  For PFHxS the 
association was not significant when the children were divided into the three age groups, 
although the 4-year-olds showed an increase of 7.6% in serum levels per month of 
breastfeeding with p=0.053 (Table 5). As with maternal PFAA concentrations, growth 
dilution, excretion and exposure from sources other than breastfeeding most likely 
contributed to this decrease in importance of early life exposure.  
Studies of 3-year-old children from Norway and children <3.5 years old from the U.S. have 
found similar results as among our 4-year-old children, with PFOS and PFOA concentrations 
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increasing 3-6% per month of breastfeeding.20 60 A study from the Faroe Islands showed 
much stronger associations between breastfeeding duration and child PFAA concentrations, 
with concentrations of PFOS and PFOA increasing with 30% per month of breastfeeding in 
fully nursed children at ages 1.5 and 5 years.21 In children from the Faroe Islands 
concentrations of PFNA and PFDA increased about 20% per month of breastfeeding,21 
whereas Norwegian 20 and U.S. children 60 showed similar results to the present study with no 
associations between time of breastfeeding and increase in serum concentrations for PFNA 
and PFDA. 
We tested the hypothesis that body weight could influence serum PFAA concentrations, 
through an effect on volume of distribution. This was only indicated for PFOA, for which 
concentrations significantly decreased with increased body weight (R2=0.05), giving some 
support to this hypothesis. Among 3-month-old POPUP infants sampled 1996-1999 no 
association between PFOA serum concentrations and weight gain from birth was observed.38 
Instead, PFHpA concentrations were negatively associated with weight gain. Although, both 
studies give some support to an influence of growth dilution on child PFAA concentrations, 
more controlled studies are needed in order to draw firm conclusions about the influence of 
growth dilution on serum PFAA concentrations during childhood. The fact that PFAA do not 
appreciably partition into fat may have contributed to the weak or non-significant 
associations with weight of the children. 61 
Overall, divergent associations were observed between year of sampling, 2008-2015, and 
PFAS concentrations over the 7 year sampling period. For example, PFOA displayed an 
inverse associations with sampling year (-7.6% per year) whereas PFHxS displayed a positive 
association (7.5% per year) (Table 4). PFOS also displayed an inverse association (-3.4% per 
year), but this was not statistically significant. Similar trends were previously reported in 
POPUP mothers between 1996 and 2012,42 55 and are attributed to a) decreased exposure to 
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PFOS and PFOA, and their precursors, due to the phase out of production of these PFASs, 
and b) cumulative long-term drinking water PFHxS exposure in the Uppsala area.37 
The basic regression models used by us only included covariates significantly associated with 
PFAA concentrations at the p≤0.1 significance levels in univariate analyses. An analysis 
using a regression model with all possible covariates (full model) was done in order to 
determine if the partial regression coefficients changed significantly compared with the basic 
models (Supporting Information, Table A9). When comparing the results of the two MRL 
analyses including children of all ages (Supporting Information, Tables A8 and A9) only 
slight differences in mean percent changes or significance levels were found. As expected the 
R2 of the full models were in many cases slightly higher, but they did not differ markedly 
from those of the basic model. This shows that the covariates with significance levels p>0.1 
in univariate analyses only explained a small fraction of the variation in serum PFAA 
concentrations. Only two statistically significant association became non-significant when 
using the full model, i.e. PFBS and age, and PFOA and body weight. A few marginally non-
significant associations in the basic model became significant in the full model. Similarly as 
for 8-year-olds, the adjusted mean PFOA concentration among 12-year-olds was lower than 
that of 4-year-old. %br PFHxS decreased as number of months of breastfeeding increased. 
Most importantly, however, among the covariates not included in the basic models for 
PFHpA and PFDA, sampling year was signficantly associated (negative) in the full model. 
This may indicate that PFHpA and PFDA exposure of Swedish children decreased between 
2008 and 2015. 
 
Drinking water exposure 
When including all children in the MLR models, serum concentrations in children increased 
with increasing drinking water exposure for PFOA, PFBS, PFHxS, and PFOS (Table 4). The 
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strongest associations were observed for PFBS and PFHxS, for which drinking water 
exposure explained 20% and 41%, respectively, of the variation in serum concentrations. 
Serum concentrations increased by 207% and 7.4% per month of cumulative PFBS and 
PFHxS drinking water exposure, respectively. This shows that drinking water is an important 
exposure medium for PFBS and PFHxS for children even in cases when drinking water 
contamination is moderate to low as in the Uppsala case. In the contaminated production 
wells in Uppsala, the median PFHxS concentration was 80 ng L-1, followed by PFOS (50 ng 
L-1) and PFBS (10 ng L-1) in samples collected 2012-2014.37 PFOA was detected in one fifth 
of the samples in these production wells, at a detection limit of 10 ng L-1. Concentrations in 
drinking water before 2012 are not known, but the PFBS and PFHxS concentrations in serum 
from POPUP mothers living in areas receiving potentially contaminated drinking water were 
elevated already between 1996 and 1999 and only slightly lower than concentrations in 
mothers living in the same areas from 2008 to 2011.37 This suggests that contamination of the 
drinking water may not have been markedly lower between 1996 and 1999 compared to 
2012. The (on average) 1.2% increase in PFOA serum concentration per month of cumulative 
PFOA drinking water exposure among the children (Table 4) suggests that even low PFOA 
contamination may be enough to significantly influence total PFOA exposure in children with 
background exposure from other sources. PFOS serum concentrations in the children 
increased on average 0.9% per month of cumulative PFOS drinking water exposure (Table 
4). These results differ from mothers to the children in the present study, where drinking 
water exposure was not associated with increased PFOS levels, although PFOS 
concentrations in the production wells were clearly elevated from background.37 The much 
higher exposure to PFOS from food than of PFBS and PFHxS 3 may mask contributions of 
drinking water exposure to serum PFOS concentrations. 
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The %br PFHxS and %br PFOS in children’s serum were positively associated with 
cumulative drinking water exposure, with a stronger association for %br PFHxS (R2=0.15) 
than for %br PFOS (R2=0.02) (Table 4). The results support earlier findings that enrichment 
of br PFHxS isomers in serum samples relative to proportions observed in the general 
population could possibly be used as marker of exposure to PFAA polluted drinking water 
caused by contamination from fire-fighting training areas.37 We hypothesize that higher 
percentages of br PFOS isomers in children with higher cumulative exposure to contaminated 
drinking water also was caused by enrichment of br PFOS isomers in contaminated drinking 
water. The proportion of br PFOS isomers in Uppsala drinking water has been determined to 
be on average 53%,37 which is considerably higher than the 30% contribution in the major 
commercial product.54  It is possible that the enrichment of br isomers in drinking water is 
due to the preferential leaching of br PFOS into the drinking water supply 62 and/or 
preferential biodegradation of br PFOS-precursors during water treatment.5 The elevated 
exposure to drinking water PFOS in this study may also have contributed to the higher %br 
PFOS (37%) in the Uppsala children compared to percentages reported in other studies of 
children from Denmark and the U.S (32% and 29% respectively), which most likely are 
exposed from other, generally dominating pathways (i.e. ingestion of food, dust, etc.).46, 48  
In conclusion, early life exposure to PFOA, PFHxS, and PFOS is an important determinant of 
serum concentrations in children, with the strongest influence on younger ages. Drinking 
water with low to moderate PFBS, PFHxS, PFOS, and PFOA contamination is an important 
source of exposure for children with background exposure from other sources.  
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Table 1. Characteristics of the children 
Age Characteristics n Mean Range % 
4 years Age (years) 57 3.9 3.3-5.1  
 Sampling year 2008-2009 6   11 
                         2010-2012 24   42 
                         2013-2015 27   47 
 Weight (kg) 57 17 13-23  
 Time of breastfeeding (months) 57 6.8 1- >13  
 Girls 21   37 
 Boys 36   63 
 DW exposurea                    PFHpA 57 0.38 0-1.9  
 (cumulative PFAA months)   PFOA 57 4.1 0-17  
                                             PFBS 57 0.17 0-0.91  
                                             PFHxS 57 5.1 0-23  
                                             PFOS 57 4.5 0-19  
8 years Age (years) 55 8.4 7.3-9.6  
 Sampling year 2008-2009 16   29 
                         2010-2012 20   36 
                         2014-2015 19   35 
 Weight (kg) 54 29 20-44  
 Time of breastfeeding (months) 55 7.1 0.5->13  
 Girls 21   38 
 Boys 34   62 
 DW exposurea                    PFHpA 55 0.29 0-2.0  
 (cumulative PFAA months)   PFOA 55 3.2 0-32  
                                             PFBS 55 0.13 0-0.91  
                                             PFHxS 55 4.6 0-48  
                                             PFOS 55 3.7 0-38  
12 years Age (years) 119 12.2 11.1-13.2  
 Sampling year 2008-2009 31   26 
                         2010-2012 76   64 
                         2014 12   10 
 Weight (kg) 113 44 28-67  
 Time of breastfeeding (months) 117 6.3 0- >13  
 Girls 56   47 
 Boys 63   53 
 DW exposurea                    PFHpA 119 0.44 0-1.9  
 (cumulative PFAA months)   PFOA 119 5.0 0-31  
                                             PFBS 119 0.20 0-0.91  
                                             PFHxS 119 8.0 0-54  
                                             PFOS 119 6.0 0-38  
aCumulative exposure to PFAA from drinking water during the whole life-time until 
sampling.  
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Table 2.  Perfluoroalkyl carboxylic acid (PFCA) serum concentrations in children at 4 
(n=57), 8 (n=55), and 12 (n=119) years of age (ng g-1 serum)              
Children Age Mean      SD Median  Range DFa (%) 
PFHpA 4 0.18 0.18 0.12 <0.08-1.0 79 
 8 0.12 0.11 0.08 <0.08-0.75 60 
 12 0.09 0.06 0.08 <0.08-0.52 51 
PFOA 4 2.7 1.3 2.5 0.86-8.3 100 
 8 2.1 0.81 2.0 <0.80-4.0 98 
 12 2.1 0.70 2.0 0.86-4.0 100 
PFNA 4 0.85 0.79 0.67 0.26-5.5 100 
 8 0.76 0.33 0.69 0.34-2.1 100 
 12 0.67 0.46 0.59 <0.08-3.9 99 
PFDA 4 0.26 0.11 0.25 <0.10-0.54 98 
 8 0.30 0.11 0.29 <0.10-0.67 96 
 12 0.25 0.092 0.23 <0.10-0.52 99 
PFUnDA 4 0.21 0.12 0.18 <0.10-0.77 74 
 8 0.20 0.079 0.18 <0.10-0.46 78 
 12 0.17 0.071 0.16 <0.10-0.51 65 
PFDoDA 4   <0.08 <0.08-0.21 12 
 8   <0.08 <0.08-0.07 2 
 12   <0.08 <0.08-0.06 1 
PFTrDA 4 0.03 0.05 <0.02 <0.02-0.35 35 
 8 0.03 0.02 0.02 <0.02-0.13 51 
 12 0.02 0.02 <0.02 <0.02-0.10 29 
PFTeDA 4   <0.06 <0.06-0.43 11 
 8   <0.06  0 
 12   <0.06 <0.06-0.10 3 
PFPeDA 4   <0.01 <0.01-0.06 4 
 8   <0.01 <0.01-0.04 2 
 12   <0.01 <0.01-0.02 1 
 
aDetection frequency.                       
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Table 3. Perfluoroalkane sulfonic acid (PFSA) serum concentrations in children at 4 
(n=57), 8 (n=55), and 12 (n=119) years of age (ng g-1 serum)            
Children Age Mean      SD Median  Range DFa (%) 
PFBS 4 0.03 0.03 0.02 <0.01-0.11 65 
 8 0.02 0.02 <0.01 <0.01-0.09 44 
 12 0.03 0.03 0.02 <0.01-0.23 60 
lin PFHxS 4 6.5 6.3 4.6 0.55-35 100 
 8 3.6 5.0 1.5 0.41-29 100 
 12 3.5 5.0 1.5 0.41-23 100 
br PFHxS 4 0.39 0.42 0.20 <0.01-1.6 98 
 8 0.23 0.35 0.07 <0.01-1.6 96 
 12 0.27 0.43 0.08 <0.01-2.6 90 
%br PFHxS 4 5.1 2.1 5.0 0.25-9.5 100 
 8 4.8 2.3 4.5 0.53-11 100 
 12 5.7 3.1 5.3 0.23-12 100 
Total PFHxS 4 6.9 6.7 5.0 0.60-37 100 
 8 3.9 5.4 1.6 0.43-30 100 
 12 3.8 5.4 1.6 0.43-26 100 
lin PFOS 4 2.9 1.6 2.4 0.87-7.1 100 
 8 3.8 2.7 3.2 1.3-19 100 
 12 3.7 1.8 3.4 1.2-9.7 100 
br PFOS 4 1.8 0.93 1.5 0.51-4.2 100 
 8 2.1 1.0 1.8 0.76-4.7 100 
 12 2.1 0.95 1.9 0.80-5.1 100 
%br PFOS 4 38 6.4 38 26-56 100 
 8 37 7.2 38 18-50 100 
 12 37 6.9 37 17-54 100 
Total PFOS 4 4.7 2.4 3.8 1.4-11 100 
 8 5.9 3.5 4.9 2.5-23 100 
 12 5.9 2.6 5.3 2.1-14 100 
 
aDetection frequency.            
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Table 4. Mean percent changes (standard error) [partial R2]a of serum concentrations of PFAA in children, (n=198, aged 4, 8, and 12 years),  1 
per unit change of each variable, assessed via multiple linear regression analysisb 2 
 Drinking water 
exposure 
(Cumulative 
PFAA months) 
Maternal serum 
conc (ng g-1 
serum) 
Time of 
breastfeeding 
(Months) 
Sampling year 
(Years) 
Weight 
(kg) 
Sex R2c  
 
n  
PFCA         
PFHpAd 1.5 (5.0) 
p=0.76 
e e - -0.47 (0.60)    
p=0.43 
- 0.14 188 
PFOA 1.2 (0.41) [0.06]   
p=0.004 
10 (3.4) [0.04]   
p=0.001 
1.4 (1.2)    
p=0.25 
-7.6 (1.5) [0.12] 
p<0.001 
-1.0 (0.46) [0.05] 
p=0.039 
- 0.30 148 
PFNA f 15 (19) 
p=0.36 
-0.31 (1.5)   
p=0.83 
- - - 0.02 149 
PFDA f 12 (35)    
p=0.67 
2.2 (1.3)   
p=0.090 
- - -8.1 (5.8)    
p=0.17 
0.06 151 
PFSA         
PFBSd 207 (52) [0.20] 
p<0.001 
e e 
 
- - - 0.22 198 
Total PFHxS 7.4 (0.53) [0.41] 
p<0.001 
10 (1.6) [0.11] 
p<0.001 
3.9 (2.0) [0.01] 
p=0.046 
 
7.5 (3.0) [0.01] 
p=0.009 
-1.1 (0.75)   
p=0.16 
 
- 0.75 147 
%br PFHxS 0.11 (0.02) [0.15] 
p<0.001 
-0.06 (0.08)  
p=0.48 
-0.16 (0.08)   
p=0.054 
-0.32 (0.12) [0.03] 
p=0.009 
- - 0.20 153 
Total PFOS 0.93 (0.44) [0.02]    
p=0.034 
 
1.3 (0.55) [0.03] 
p=0.015 
3.8 (1.5) [0.04]  
p=0.010 
-3.4 (2.1)   
p=0.10 
-0.32 (0.57)   
p=0.58 
-11 (6.2) 
p=0.081 
0.16 148 
%br PFOS 0.14 (0.06) [0.02]  
p=0.033 
0.28 (0.10) [0.04]   
p=0.004 
-0.006 (0.22)   
p=0.98 
- - - 0.07 151 
- = the covariate was not significantly associated in the univariate linear regression (p≥0.1) and was therefore not included in the total model. 3 
aPartial coefficient of determination from stepwise regression analyses. 4 
bThe categories age 4, 8, and 12 years, with age 4 as the reference category, were also adjusted for in the multiple linear regression analyses. 5 
cCoefficient of determination for the whole regression model. 6 
d>25% below MQL. 7 
eNot included in the regression model due to short half-life. 8 
fNot detected in the drinking water.9 
 Table 5. Percent change (standard error) [partial R2]a in PFAA serum concentrations 
per unit change of maternal PFAA serum concentration (ng g-1 serum) and nursing 
duration (months) in children at 4 (n=57), 8 (n=55), and 12 (n=119) years of age, 
assessed via multiple linear regression analysisb 
 
Age 
Maternal serum 
conc (ng g-1 
serum) 
Time of 
breastfeeding 
(months) 
R2c  n 
PFOA 4 29 (7.8) [0.24] 
p<0.001 
5.1 (2.4) [0.05]   
p=0.034 
0.42 52 
 8 3.1 (7.1)    
 p=0.66 
1.7 (2.2)   
p=0.42 
0.42 40 
 12 8.4 (3.9) [0.04]   
p=0.026 
-1.9 (1.3)  
p=0.15 
0.21 87 
Total PFHxS 4 11 (1.7) [0.29] 
p<0.001 
7.6 (4.1) 
p=0.053 
0.69 52 
 8 9.7 (5.6)    
 p=0.071 
-0.18 (3.0)    
p=0.95 
0.73 40 
 12 7.2 (5.6)     
 p=0.18 
2.7 (2.5)   
p=0.28 
0.68 85 
Total PFOS 4 5.6 (1.5) [0.24] 
p=0.001 
7.9 (2.8) [0.10] 
p=0.005 
0.39 51 
 8 -0.86 (1.2)   
p=0.49 
5.3 (2.6) [0.08]   
p=0.038 
0.27 40 
 12 1.1 (0.59) 
p=0.054 
1.7 (1.7)   
p=0.34 
0.13 86 
%br PFOS 4 0.20 (0.14) 
p=0.14 
0.33 (0.41)    
p=0.43 
0 51 
 8 0.45 (0.20) [0.09]  
p=0.031 
0.20 (0.41)   
p=0.64 
0.09 40 
 12 0.33 (0.15) [0.04]   
p=0.038 
-0.15 (0.27)     
p=0.58 
0.15 86 
aPartial coefficient of determination from stepwise regression analyses. 
bDrinking water exposure (Cumulative PFAA months) were also adjusted for in the models and the 
covariates sampling year, age, and sex if they were significantly associated in the univariate linear 
regression (p≥0.1). 
cCoefficient of determination for the whole regression model.  
26 
 
4-year-olds
8-year-olds
12-year-olds
4-year-olds
8-year-olds
12-year-olds Birth
Sampling
1996 2006 2016
 
Figure 1. Years of birth and sampling period with median, for the children in the present 
study at 4 (n=57), 8 (n=55), and 12 (n=119) years of age. 
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Figure 2. Concentrations of PFAA in children at 4 (n=50), 8 (n=49), and 12 (n=99) years of 
age, sampled 2008-2015. Concentrations are shown as least square means and standard error 
(SE) determined by general linear model (GLM) analysis adjusted for sampling year and 
drinking water exposure (cumulative PFAA months). a = significantly different from 4-year-
olds and b = significantly different from 8-year-olds (p<0.05). 
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Figure 3. Cluster analysis of PFAA based on correlations between serum concentration in 
children at 4, 8, and 12 years of age (n=198), sampled 2008-2015, using average linkage 
cluster analysis, which is a hierarchical analysis clustering method based on the average 
distance between all pairs of objects. 
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Supporting Information 
PFAAs included in the study (Table A1). Target compounds and selected instrumental 
parameters for quantification of each compound by UPLC/ESI-MS/MS (Table A2). 
Summary of analysis of in-house reference material (pooled human serum) analyzed together 
with real samples to assess inter-batch precision (i.e. reproducibility) (Table A3). PFCA 
concentrations measured in 3 replicates of NIST SRM 1957 compared to reference values 
(Table A4). PFSA concentrations measured in 3 replicates of NIST SRM 1957 compared to 
reference values (Table A5). Calculation example of cumulative exposure to PFAA from 
drinking water (Table A6). Blood PFAA concentrations in children from other studies (Table 
A7). Mean percent changes of serum PFAA concentrations including all children and results 
from the age categories, with age 4 as the reference category (Table A8). Mean percent 
changes of serum PFAA concentrations including all children and all variables in all multiple 
linear regression analyses (Table A9). Mean percent changes of serum PFAA concentrations 
for the three age groups (4, 8, and 12) separately Table A10). 
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